Skip to main

KKR-Backed Catalio Gathers $400 Million for Biotech Startups

01 Jul 2025

KKR & Co.-backed venture capital firm Catalio Capital Management gathered more than $400 million for its latest fund, a marginally larger amount than the biotech company raised for its prior vehicle.

Read more
TechCrunch: Catalio Capital closes over $400M Fund IV
WSJ: Catalio Capital Shrugs Off Sluggish Market, Tops $400 Million for Life-Sciences Fund


Category:
Sub Categories:
Share this article on social media
To read the full article, visit Bloomberg websitehttps://www.bloomberg.com/news/articles/2025-07-01/kkr-backed-catalio-gathers-400-million-for-biotech-startups website
© All rights reserved to IVC and Israel Innovation Authority
Disclaimer:
The information provided on this platform is based solely on publicly available sources collected from the internet, including news articles, press releases, company websites, and other open-access materials.
The content is provided "AS IS" for informational purposes only and should not construed as professional, legal, or investment advice.
While we strive to ensure the accuracy and timeliness of the information presented, we do not guarantee its completeness or correctness.
Users are encouraged to independently verify any data before relying on it.
IVC shall bear no liability for investment decisions based on the information provided. In no event shall IVC or its employees, agents, or affiliates be liable for any direct, indirect, actual, special, or consequential damages resulting from the use of the information provided.